DASH vs LAB
DoorDash, Inc. Class A Common Stock (DASH) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. LAB currently screens at market cap $317.1M.
Not investment advice. Open the DASH and LAB stock pages for the full models.
Not investment advice.